Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
Demet Candas-Green(University of California, Davis), Jian Jian Li(University of California Davis Medical Center), Kit S. Lam(University of California System), Omer M. Ozpiskin(University of California, Davis), Di Jing(Chinese Academy of Medical Sciences & Peking Union Medical College), William J. Murphy(University of California Davis Medical Center), Ralph R. Weichselbaum(University of Chicago), Soheila Azghadi(University of California, Davis), Andrew Vaughan(University of California, Davis), Tianyi Gao(University of California, Davis), Arta M. Monjazeb(University of California Davis Medical Center), Nian Jiang(University of Minnesota), David J. Grdina(University of Chicago), Tzu‐yin Lin(University of California, Davis), Cheikh Menaa(Lawrence Livermore National Laboratory), Weibing Zhou(Central South University), Lin Liu(University of California, Davis), Lu Zhang(Qingdao University of Science and Technology), Tao Li(Hunan University), Jie Huang(Menlo School), Aijun Wang(Shriners Hospitals for Children - Erie), Lun-Quan Sun(Central South University), Bowen Xie(University of California, Davis), Rulong Shen(The Ohio State University), Ji Ming Wang(Frederick National Laboratory for Cancer Research), Shuli Xia(Johns Hopkins University), Ming Fan(Beijing Institute of Technology), Hong-Wu Chen(University of California, Davis), Chong‐Xian Pan(Brigham and Women's Hospital), Colleen Sweeney(UC Davis Health), Yanhong Zhang(Tianjin Infectious Diseases Hospital), Gayle E. Woloschak(Northwestern University)
Cited by 146
Related Papers
Short-term meditation training improves attention and self-regulation
|Proceedings of the National Academy of Sciences|2007|1.6k
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
Central and autonomic nervous system interaction is altered by short-term meditation
|Proceedings of the National Academy of Sciences|2009|680
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
|Nature Communications|2017|474